DABUR INDIA LTD.

Dabur India Ltd has received an Import Alert (IA) 66-40 from the US FDA for drugs manufactured at its Silvassa plant, following an inspection that identified deficiencies in data integrity and maintenance. The company states there is no violation and no financial or operational impact, as the alert pertains to a small segment of private label products generating insignificant revenue. Domestic products are unaffected, and the plant remains operational. Dabur is engaging with the US FDA on corrective actions and exploring alternate sourcing for US customers.

Dabur India Ltd clarified a news item regarding USFDA observations at its manufacturing plant in Silvassa, Dadra & Nagar Haveli. The company stated that the observations concern a small part of their operations, generating insignificant revenue. Dabur is actively engaged with the USFDA and has shared a corrective action plan. The company reiterates its commitment to quality, safety, and compliance, stating there is no impact on financials or operations.

Dabur International Limited, a step-down wholly owned subsidiary of Dabur India Limited, has incorporated a new wholly owned subsidiary named 'PRAVAAH CONSUMER GROUP INC.' in Delaware, USA, effective May 15, 2026. The incorporation certificate was received on May 18, 2026. This information is available on Dabur's website.

Dabur India Ltd has set July 17, 2026, as the record date to determine shareholders eligible for the final dividend of ₹5.50 per share (550%) for FY26, subject to shareholder approval at the AGM on August 06, 2026. The book closure period is scheduled from July 20, 2026, to July 24, 2026. Dividend payment, if approved, will be made on or before September 04, 2026.

Dabur India Ltd has announced a final dividend of ₹5.50 per share (550%) for the financial year 2025-26, subject to shareholder approval at the upcoming Annual General Meeting (AGM) scheduled for August 06, 2026. The company has fixed the book closure dates from July 20, 2026, to July 24, 2026, and the record date as July 17, 2026, to determine shareholders' eligibility for the dividend. If approved, the dividend payment will be made on or before September 04, 2026.

The Board of Directors of Dabur India Ltd, based on the recommendation of the Nomination and Remuneration Committee, has approved the re-appointment of Mr. Rajiv Mehrishi as Non-Executive Independent Director for a second term of 5 years, effective September 01, 2026. It also modified the tenure of Mr. Mukesh Hari Butani's second term as Non-Executive Independent Director to one year, from January 1, 2026. Additionally, Mr. Saket Burman has been re-appointed as Non-Executive Director, subject to shareholder approval at the upcoming AGM.

Dabur India Ltd's Board of Directors has recommended a final dividend of ₹5.50 per equity share (550%) for the financial year 2025-26, subject to shareholder approval at the upcoming Annual General Meeting. The AGM is scheduled for August 6, 2026, and will be held via video conferencing. The board also approved the financial results for the quarter and year ended March 31, 2026, with an unmodified opinion from the statutory auditors.

Dabur India Ltd's board approved audited financial results for the quarter and year ended March 31, 2026, with an unmodified audit opinion. A final dividend of ₹5.50 per share (550%) has been recommended for FY26, subject to shareholder approval at the AGM scheduled for August 6, 2026. The results will be published in Mint and Deshbandhu on May 8, 2026, and are available on the company's and stock exchanges' websites.

Dabur India Ltd announced its audited financial results for the quarter and financial year ended March 31, 2026. The Board of Directors approved the consolidated and standalone financial results and recommended a final dividend of ₹5.50 per equity share. The 51st Annual General Meeting will be held on August 6, 2026, via video conferencing.

Dabur India Ltd announced its audited financial results for the quarter and financial year ended March 31, 2026. The Board of Directors approved the consolidated and standalone financial results and recommended a final dividend of ₹5.50 per equity share. The 51st Annual General Meeting will be held on August 6, 2026, via video conferencing.